These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16618650

  • 1. Functional outcome of treatment of Ménière's disease with the Meniett pressure generator.
    Stokroos R, Olvink MK, Hendrice N, Kingma H.
    Acta Otolaryngol; 2006 Mar; 126(3):254-8. PubMed ID: 16618650
    [Abstract] [Full Text] [Related]

  • 2. Meniett therapy: rescue treatment in severe drug-resistant Ménière's disease?
    Boudewyns AN, Wuyts FL, Hoppenbrouwers M, Ketelslagers K, Vanspauwen R, Forton G, Van de Heyning PH.
    Acta Otolaryngol; 2005 Dec; 125(12):1283-9. PubMed ID: 16303675
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
    Rajan GP, Din S, Atlas MD.
    J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
    [Abstract] [Full Text] [Related]

  • 4. Effects of middle ear pressure changes on clinical symptoms in patients with Ménière's disease--a clinical multicentre placebo-controlled study.
    Odkvist LM, Arlinger S, Billermark E, Densert B, Lindholm S, Wallqvist J.
    Acta Otolaryngol Suppl; 2000 May; 543():99-101. PubMed ID: 10908991
    [Abstract] [Full Text] [Related]

  • 5. Local pressure protocol, including Meniett, in the treatment of Ménière's disease: short-term results during the active stage.
    Barbara M, Consagra C, Monini S, Nostro G, Harguindey A, Vestri A, Filipo R.
    Acta Otolaryngol; 2001 Dec; 121(8):939-44. PubMed ID: 11813899
    [Abstract] [Full Text] [Related]

  • 6. The effect of the Meniett device in patients with Ménière's disease: long-term results.
    Dornhoffer JL, King D.
    Otol Neurotol; 2008 Sep; 29(6):868-74. PubMed ID: 18617868
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of the Meniett device in Japanese patients with Meniere's disease and delayed endolymphatic hydrops reported by the Middle Ear Pressure Treatment Research Group of Japan.
    Shojaku H, Watanabe Y, Mineta H, Aoki M, Tsubota M, Watanabe K, Goto F, Shigeno K.
    Acta Otolaryngol; 2011 Mar; 131(3):277-83. PubMed ID: 21319947
    [Abstract] [Full Text] [Related]

  • 8. Influence of Meniett® treatment on hearing.
    Barbara M, Lazzarino AI, Biagini M, Costa M, Monini S.
    Acta Otolaryngol; 2010 Nov; 130(11):1256-9. PubMed ID: 20446875
    [Abstract] [Full Text] [Related]

  • 9. Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.
    Gürkov R, Filipe Mingas LB, Rader T, Louza J, Olzowy B, Krause E.
    J Laryngol Otol; 2012 Apr; 126(4):356-62. PubMed ID: 22365373
    [Abstract] [Full Text] [Related]

  • 10. Meniett clinical trial: long-term follow-up.
    Gates GA, Verrall A, Green JD, Tucci DL, Telian SA.
    Arch Otolaryngol Head Neck Surg; 2006 Dec; 132(12):1311-6. PubMed ID: 17178941
    [Abstract] [Full Text] [Related]

  • 11. Control of symptoms in patients with Meniere's disease using middle ear pressure applications: two years follow-up.
    Densert B, Sass K.
    Acta Otolaryngol; 2001 Jul; 121(5):616-21. PubMed ID: 11583396
    [Abstract] [Full Text] [Related]

  • 12. Intermittent pressure therapy of intractable Meniere's disease and delayed endolymphatic hydrops using the transtympanic membrane massage device: a preliminary report.
    Watanabe Y, Shojaku H, Junicho M, Asai M, Fujisaka M, Takakura H, Tsubota M, Yasumura S.
    Acta Otolaryngol; 2011 Nov; 131(11):1178-86. PubMed ID: 21838607
    [Abstract] [Full Text] [Related]

  • 13. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C, Franco-Vidal V, Bebear JP, Darrouzet V.
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [Abstract] [Full Text] [Related]

  • 14. The effects of transtympanic micropressure treatment in people with unilateral Meniere's disease.
    Gates GA, Green JD, Tucci DL, Telian SA.
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):718-25. PubMed ID: 15210552
    [Abstract] [Full Text] [Related]

  • 15. Meniett therapy may avoid vestibular neurectomy in disabling Meniere's disease.
    Barbara M, Monini S, Chiappini I, Filipo R.
    Acta Otolaryngol; 2007 Nov; 127(11):1136-41. PubMed ID: 17851896
    [Abstract] [Full Text] [Related]

  • 16. Systematic review and meta-analysis of Meniett therapy for Meniere's disease.
    Ahsan SF, Standring R, Wang Y.
    Laryngoscope; 2015 Jan; 125(1):203-8. PubMed ID: 24913022
    [Abstract] [Full Text] [Related]

  • 17. Dexamethasone inner ear perfusion by intratympanic injection in unilateral Ménière's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.
    Garduño-Anaya MA, Couthino De Toledo H, Hinojosa-González R, Pane-Pianese C, Ríos-Castañeda LC.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):285-94. PubMed ID: 16087029
    [Abstract] [Full Text] [Related]

  • 18. Intermittent pressure therapy of intractable Ménière's disease using the Meniett device: a preliminary report.
    Gates GA, Green JD.
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1489-93. PubMed ID: 12172267
    [Abstract] [Full Text] [Related]

  • 19. [Middle ear overpressure with Meniett in Menière disease: indications, results at short and middle terms in 53 cases].
    Faict H, Bouccara D.
    Rev Laryngol Otol Rhinol (Bord); 2007 Aug; 128(1-2):33-6. PubMed ID: 17633662
    [Abstract] [Full Text] [Related]

  • 20. Three new surgeries for treatment of intractable Meniere's disease.
    Huang TS.
    Am J Otol; 1999 Mar; 20(2):233-7. PubMed ID: 10100528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.